New! Sign up for our email newsletter on Substack.

NASA to showcase innovative research for treating blindness

A technology designed to restore vision in patients suffering from age-related blindness will be demonstrated by a scientist at NASA Ames Research Center in California’s Silicon Valley today. Developed by NASA Ames in conjunction with the Stanford University School of Medicine, the “Vision Chip” may help improve age-related macular degeneration, the number one cause of blindness in the elderly. “Nanotechnology that could restore vision is an exciting example of how NASA science and engineering, origially intended for outer space, can return enormous dividends for everyday life here on Earth,” said Dr. David J. Loftus, a member of both the Life Sciences Division and the Integrated Product Team on Devices and Nanotechnology at NASA Ames.
From NASA:
NASA TO SHOWCASE INNOVATIVE RESEARCH FOR TREATING BLINDNESS

A technology designed to restore vision in patients suffering from age-related blindness will be demonstrated by a scientist at NASA Ames Research Center in California’s Silicon Valley on Friday, Dec. 6. Organized by the Girvan Institute of Technology, a non-profit public benefit corporation located at the NASA Research Park (NRP), the demo will be held from 9:30 a.m. to 12:00 p.m. PST in Bldg. 3.

Developed by NASA Ames in conjunction with the Stanford University School of Medicine, the “Vision Chip” may help improve age-related macular degeneration, the number one cause of blindness in the elderly.

“Nanotechnology that could restore vision is an exciting example of how NASA science and engineering, origially intended for outer space, can return enormous dividends for everyday life here on Earth,” said Dr. David J. Loftus, a member of both the Life Sciences Division and the Integrated Product Team on Devices and Nanotechnology at NASA Ames.

This device consists of an array of electrically conductive carbon nanotube (CNT) towers grown directly on the surface of a silicon chip. The CNT towers allow signals captured from a charge-coupled device (CCD) to be transmitted directly to the neural elements of the retina, potentially restoring vision.


Did this article help you?

If you found this piece useful, please consider supporting our work with a small, one-time or monthly donation. Your contribution enables us to continue bringing you accurate, thought-provoking science and medical news that you can trust. Independent reporting takes time, effort, and resources, and your support makes it possible for us to keep exploring the stories that matter to you. Together, we can ensure that important discoveries and developments reach the people who need them most.